Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
cyclopropane | [no description available] | medium | 8 | 0 | cycloalkane; cyclopropanes | inhalation anaesthetic |
2-chloroethylamine | [no description available] | medium | 7 | 0 | | |
pituitrin | [no description available] | medium | 9 | 0 | | |
tolazoline | [no description available] | medium | 29 | 0 | imidazoles | alpha-adrenergic antagonist; antihypertensive agent; vasodilator agent |
papaverine | [no description available] | medium | 21 | 0 | benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines | antispasmodic drug; vasodilator agent |
nitroglycerin | [no description available] | medium | 2 | 0 | nitroglycerol | explosive; muscle relaxant; nitric oxide donor; prodrug; tocolytic agent; vasodilator agent; xenobiotic |
glycerol | [no description available] | medium | 2 | 0 | alditol; triol | algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent |
nitrites | [no description available] | medium | 3 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | human metabolite |
nitrates | [no description available] | medium | 2 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | |
prazosin | [no description available] | medium | 6 | 0 | aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
phenoxybenzamine | [no description available] | medium | 85 | 0 | aromatic amine | |
oxymetazoline | [no description available] | medium | 5 | 0 | carboxamidine; imidazolines; phenols | alpha-adrenergic agonist; nasal decongestant; sympathomimetic agent; vasoconstrictor agent |
cirazoline | [no description available] | medium | 1 | 0 | aromatic ether | |
szl 49 | [no description available] | medium | 2 | 0 | | |
a 61603 | [no description available] | medium | 1 | 0 | tetralins | |
atropine | [no description available] | medium | 85 | 0 | | |
methantheline | [no description available] | medium | 2 | 0 | xanthenes | |
sodium salicylate | [no description available] | medium | 4 | 0 | organic molecular entity | |
salicylates | [no description available] | medium | 1 | 0 | monohydroxybenzoate | plant metabolite |
iodine | [no description available] | medium | 6 | 0 | diatomic iodine | nutrient |
thiouracil | [no description available] | medium | 2 | 0 | nucleobase analogue; thiocarbonyl compound | antithyroid drug; metabolite |
choline | [no description available] | medium | 8 | 0 | cholines | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter; nutrient; plant metabolite; Saccharomyces cerevisiae metabolite |
dibenzylamine | [no description available] | medium | 2 | 0 | aromatic amine | |
cortisone | [no description available] | medium | 3 | 0 | 11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite |
mescaline | [no description available] | medium | 2 | 0 | methoxybenzenes; phenethylamine alkaloid; primary amino compound | hallucinogen |
mechlorethamine | [no description available] | medium | 2 | 0 | nitrogen mustard; organochlorine compound | alkylating agent |
glucagon | [no description available] | medium | 2 | 0 | peptide hormone | |
acetazolamide | [no description available] | medium | 2 | 0 | monocarboxylic acid amide; sulfonamide; thiadiazoles | anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
chlorpromazine | [no description available] | medium | 32 | 0 | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
tripelennamine | [no description available] | medium | 2 | 0 | aromatic amine | |
ephedrine | [no description available] | medium | 6 | 0 | phenethylamine alkaloid; phenylethanolamines | bacterial metabolite; environmental contaminant; nasal decongestant; plant metabolite; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
phentolamine | [no description available] | medium | 82 | 0 | imidazoles; phenols; substituted aniline; tertiary amino compound | alpha-adrenergic antagonist; vasodilator agent |
hydralazine | [no description available] | medium | 5 | 0 | azaarene; hydrazines; ortho-fused heteroarene; phthalazines | antihypertensive agent; vasodilator agent |
hydrogen carbonate | [no description available] | medium | 2 | 0 | carbon oxoanion | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
triethylammonium bicarbonate | [no description available] | medium | 1 | 0 | | |
reserpine | [no description available] | medium | 64 | 0 | alkaloid ester; methyl ester; yohimban alkaloid | adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic |
arginine vasopressin | [no description available] | medium | 1 | 0 | vasopressin | cardiovascular drug; hematologic agent; mitogen |
piperoxan | [no description available] | medium | 2 | 0 | | |
pentobarbital | [no description available] | medium | 7 | 0 | barbiturates | GABAA receptor agonist |
2-naphthylamine | [no description available] | medium | 1 | 0 | naphthylamine | carcinogenic agent |
iproniazid | [no description available] | medium | 8 | 0 | carbohydrazide; pyridines | |
ergotamine | [no description available] | medium | 28 | 0 | peptide ergot alkaloid | alpha-adrenergic agonist; mycotoxin; non-narcotic analgesic; oxytocic; serotonergic agonist; vasoconstrictor agent |
phlorhizin | [no description available] | medium | 1 | 0 | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | antioxidant; plant metabolite |
yohimbine | [no description available] | medium | 20 | 0 | methyl 17-hydroxy-20xi-yohimban-16-carboxylate | alpha-adrenergic antagonist; dopamine receptor D2 antagonist; serotonergic antagonist |
physostigmine | [no description available] | medium | 18 | 0 | carbamate ester; indole alkaloid | antidote to curare poisoning; EC 3.1.1.8 (cholinesterase) inhibitor; miotic |
phenothiazine | [no description available] | medium | 1 | 0 | phenothiazine | ferroptosis inhibitor; plant metabolite; radical scavenger |
prenylamine | [no description available] | medium | 3 | 0 | diarylmethane | |
dipyridamole | [no description available] | medium | 3 | 0 | piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol | adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent |
khellin | [no description available] | medium | 1 | 0 | furanochromone; organic heterotricyclic compound; oxacycle | anti-asthmatic agent; bronchodilator agent; cardiovascular drug; vasodilator agent |
guanethidine | [no description available] | medium | 22 | 0 | azocanes; guanidines | adrenergic antagonist; antihypertensive agent; sympatholytic agent |
procaine | [no description available] | medium | 5 | 0 | benzoate ester; substituted aniline; tertiary amino compound | central nervous system depressant; drug allergen; local anaesthetic; peripheral nervous system drug |
carbachol | [no description available] | medium | 21 | 0 | ammonium salt; carbamate ester | cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic |
4-aminobenzoic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; aromatic amino-acid zwitterion | allergen; Escherichia coli metabolite; plant metabolite |
histamine | [no description available] | medium | 35 | 0 | aralkylamino compound; imidazoles | human metabolite; mouse metabolite; neurotransmitter |
isoproterenol | [no description available] | medium | 100 | 0 | catechols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent |
pheniprazine | [no description available] | medium | 1 | 0 | amphetamines | |
hydrazine | [no description available] | medium | 5 | 0 | azane; hydrazines | EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor |
methylphenidate | [no description available] | medium | 2 | 0 | beta-amino acid ester; methyl ester; piperidines | |
amphetamine | [no description available] | medium | 8 | 0 | primary amine | |
cocaine | [no description available] | medium | 36 | 0 | benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid | adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
dichloroisoproterenol | [no description available] | medium | 2 | 0 | | |
phenylephrine | [no description available] | medium | 42 | 0 | phenols; phenylethanolamines; secondary amino compound | alpha-adrenergic agonist; cardiotonic drug; mydriatic agent; nasal decongestant; protective agent; sympathomimetic agent; vasoconstrictor agent |
triflupromazine | [no description available] | medium | 1 | 0 | organofluorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; first generation antipsychotic |
thioridazine | [no description available] | medium | 2 | 0 | phenothiazines; piperidines | alpha-adrenergic antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist |
chloralose | [no description available] | medium | 1 | 0 | | |
urethane | [no description available] | medium | 3 | 0 | carbamate ester | fungal metabolite; mutagen |
hexobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
nicotine | [no description available] | medium | 15 | 0 | 3-(1-methylpyrrolidin-2-yl)pyridine | anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic |
tyramine | [no description available] | medium | 20 | 0 | monoamine molecular messenger; primary amino compound; tyramines | EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter |
acetaldehyde | [no description available] | medium | 1 | 0 | aldehyde | carcinogenic agent; EC 3.5.1.4 (amidase) inhibitor; electron acceptor; Escherichia coli metabolite; human metabolite; mouse metabolite; mutagen; oxidising agent; Saccharomyces cerevisiae metabolite; teratogenic agent |
meprobamate | [no description available] | medium | 4 | 0 | organic molecular entity | |
chlorisondamine | [no description available] | medium | 2 | 0 | isoindoles | |
mephenesin | [no description available] | medium | 1 | 0 | aromatic ether; glycerol ether | |
mercaptomerin | [no description available] | medium | 1 | 0 | | |
vitamin b 12 | [no description available] | medium | 1 | 0 | | |
tetraethylammonium | [no description available] | medium | 2 | 0 | quaternary ammonium ion | |
dicumarol | [no description available] | medium | 1 | 0 | hydroxycoumarin | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; Hsp90 inhibitor; vitamin K antagonist |
meperidine | [no description available] | medium | 1 | 0 | ethyl ester; piperidinecarboxylate ester; tertiary amino compound | antispasmodic drug; kappa-opioid receptor agonist; mu-opioid receptor agonist; opioid analgesic |
methadone | [no description available] | medium | 1 | 0 | benzenes; diarylmethane; ketone; tertiary amino compound | |
hyaluronoglucosaminidase | [no description available] | medium | 2 | 0 | | |
hydantoins | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | |
tetraethyl pyrophosphate | [no description available] | medium | 1 | 0 | organic diphosphate | |
propane | [no description available] | medium | 1 | 0 | alkane; gas molecular entity | food propellant |
ouabain | [no description available] | medium | 2 | 0 | 11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone | anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite |
propranolol | [no description available] | medium | 127 | 0 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
tubocurarine | [no description available] | medium | 6 | 0 | bisbenzylisoquinoline alkaloid | drug allergen; muscle relaxant; nicotinic antagonist |
isoflurophate | [no description available] | medium | 1 | 0 | dialkyl phosphate | |
diphenhydramine | [no description available] | medium | 7 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
thyroxine | [no description available] | medium | 2 | 0 | 2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine | antithyroid drug; human metabolite; mouse metabolite; thyroid hormone |
lysergic acid diethylamide | [no description available] | medium | 9 | 0 | ergoline alkaloid; monocarboxylic acid amide; organic heterotetracyclic compound | dopamine agonist; hallucinogen; serotonergic agonist |
methyldopa | [no description available] | medium | 11 | 0 | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent |
theophylline | [no description available] | medium | 16 | 0 | dimethylxanthine | adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent |
aldosterone | [no description available] | medium | 3 | 0 | 11beta-hydroxy steroid; 18-oxo steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; mineralocorticoid; primary alpha-hydroxy ketone; steroid aldehyde | human metabolite; mouse metabolite |
pilocarpine | [no description available] | medium | 10 | 0 | pilocarpine | antiglaucoma drug |
pentylenetetrazole | [no description available] | medium | 4 | 0 | organic heterobicyclic compound; organonitrogen heterocyclic compound | |
phenytoin | [no description available] | medium | 2 | 0 | imidazolidine-2,4-dione | anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent |
phenobarbital | [no description available] | medium | 3 | 0 | barbiturates | anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative |
aminophylline | [no description available] | medium | 2 | 0 | mixture | bronchodilator agent; cardiotonic drug |
lithium | [no description available] | medium | 1 | 0 | alkali metal atom | |
manganese | [no description available] | medium | 1 | 0 | elemental manganese; manganese group element atom | Escherichia coli metabolite; micronutrient |
neostigmine | [no description available] | medium | 3 | 0 | quaternary ammonium ion | antidote to curare poisoning; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
dextromoramide | [no description available] | medium | 2 | 0 | morpholines; N-acylpyrrolidine | opioid analgesic |
haloperidol | [no description available] | medium | 6 | 0 | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
chloral hydrate | [no description available] | medium | 2 | 0 | aldehyde hydrate; ethanediol; organochlorine compound | general anaesthetic; mouse metabolite; sedative; xenobiotic |
methoxamine | [no description available] | medium | 3 | 0 | amphetamines | alpha-adrenergic agonist; antihypotensive agent |
dihydroergotamine | [no description available] | medium | 1 | 0 | ergot alkaloid; semisynthetic derivative | dopamine agonist; non-narcotic analgesic; serotonergic agonist; sympatholytic agent; vasoconstrictor agent |
oxotremorine | [no description available] | medium | 3 | 0 | N-alkylpyrrolidine | |
hexamethonium | [no description available] | medium | 2 | 0 | quaternary ammonium salt | |
thiourea | [no description available] | medium | 4 | 0 | one-carbon compound; thioureas; ureas | antioxidant; chromophore |
dimaprit | [no description available] | medium | 3 | 0 | imidothiocarbamic ester | |
4-methylhistamine | [no description available] | medium | 1 | 0 | aralkylamino compound; imidazoles | histamine agonist; metabolite |
cyclic gmp | [no description available] | medium | 2 | 0 | 3',5'-cyclic purine nucleotide; guanyl ribonucleotide | Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
fluorides | [no description available] | medium | 1 | 0 | halide anion; monoatomic fluorine | |
sodium fluoride | [no description available] | medium | 2 | 0 | fluoride salt | mutagen |
gallopamil | [no description available] | medium | 3 | 0 | benzenes; organic amino compound | |
timolol | [no description available] | medium | 2 | 0 | timolol | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist |
benzofurans | [no description available] | medium | 1 | 0 | | |
ro 03-7894 | [no description available] | medium | 1 | 0 | | |
n,n-dimethyl-n',n'-dibenzylethylenediamine | [no description available] | medium | 1 | 0 | | |
chlorine | [no description available] | medium | 4 | 0 | halide anion; monoatomic chlorine | cofactor; Escherichia coli metabolite; human metabolite |
octylonium | [no description available] | medium | 1 | 0 | benzamides | |
verapamil | [no description available] | medium | 5 | 0 | aromatic ether; nitrile; polyether; tertiary amino compound | |
furtrethonium | [no description available] | medium | 1 | 0 | aralkylamine | |
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid | [no description available] | medium | 1 | 0 | | |
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid | [no description available] | medium | 1 | 0 | stilbenoid | |
dihydro-dids | [no description available] | medium | 1 | 0 | | |
colchicine | [no description available] | medium | 1 | 0 | alkaloid; colchicine | anti-inflammatory agent; gout suppressant; mutagen |
egtazic acid | [no description available] | medium | 2 | 0 | diether; tertiary amino compound; tetracarboxylic acid | chelator |
calcimycin | [no description available] | medium | 1 | 0 | benzoxazole | |
lanthanum | [no description available] | medium | 1 | 0 | f-block element atom; lanthanoid atom; scandium group element atom | |
piperonyl butoxide | [no description available] | medium | 1 | 0 | benzodioxoles | pesticide synergist |
cobalt | [no description available] | medium | 2 | 0 | cobalt group element atom; metal allergen | micronutrient |
proadifen | [no description available] | medium | 2 | 0 | diarylmethane | |
luteoskyrin | [no description available] | medium | 1 | 0 | | |
naphthoquinones | [no description available] | medium | 1 | 0 | | |
sauvagine | [no description available] | medium | 1 | 0 | | |
alprenolol | [no description available] | medium | 2 | 0 | secondary alcohol; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
nad | [no description available] | medium | 1 | 0 | organophosphate oxoanion | cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite |
nadp | [no description available] | medium | 1 | 0 | | |
mannomustine | [no description available] | medium | 1 | 0 | amino alcohol | |
clorgyline | [no description available] | medium | 1 | 0 | aromatic ether; dichlorobenzene; terminal acetylenic compound; tertiary amino compound | antidepressant; EC 1.4.3.4 (monoamine oxidase) inhibitor |
ketamine | [no description available] | medium | 2 | 0 | cyclohexanones; monochlorobenzenes; secondary amino compound | analgesic; environmental contaminant; intravenous anaesthetic; neurotoxin; NMDA receptor antagonist; xenobiotic |
adenosine-5'-(n-ethylcarboxamide) | [no description available] | medium | 1 | 0 | adenosines; monocarboxylic acid amide | adenosine A1 receptor agonist; adenosine A2A receptor agonist; antineoplastic agent; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent |
n-methyladenosine | [no description available] | medium | 1 | 0 | methyladenosine | |
adenosine | [no description available] | medium | 1 | 0 | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
n(6)-cyclohexyladenosine | [no description available] | medium | 1 | 0 | | |
bucladesine | [no description available] | medium | 4 | 0 | 3',5'-cyclic purine nucleotide | |
galantide | [no description available] | medium | 1 | 0 | | |
substance p | [no description available] | medium | 1 | 0 | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent |
dimethyl sulfoxide | [no description available] | medium | 1 | 0 | sulfoxide; volatile organic compound | alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger |
glyburide | [no description available] | medium | 1 | 0 | monochlorobenzenes; N-sulfonylurea | anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent |
diltiazem | [no description available] | medium | 2 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent; calcium channel blocker; vasodilator agent |
spironolactone | [no description available] | medium | 1 | 0 | 3-oxo-Delta(4) steroid; oxaspiro compound; steroid lactone; thioester | aldosterone antagonist; antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
benextramine | [no description available] | medium | 1 | 0 | | |
cystamine | [no description available] | medium | 2 | 0 | organic disulfide; primary amino compound | EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor |
edetic acid | [no description available] | medium | 3 | 0 | ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid | anticoagulant; antidote; chelator; copper chelator; geroprotector |
methysergide | [no description available] | medium | 11 | 0 | ergoline alkaloid | |
tretoquinol | [no description available] | medium | 1 | 0 | isoquinolines | |
barium | [no description available] | medium | 10 | 0 | alkaline earth metal atom; elemental barium | |
pyrilamine | [no description available] | medium | 2 | 0 | aromatic ether; ethylenediamine derivative | H1-receptor antagonist |
tetragastrin | [no description available] | medium | 2 | 0 | peptidyl amide; tetrapeptide | anxiogenic; human metabolite |
metiamide | [no description available] | medium | 1 | 0 | imidazoles | |
azapetine | [no description available] | medium | 1 | 0 | benzazepine | |
mepiperphenidol | [no description available] | medium | 1 | 0 | benzenes; organic amino compound | |
piperidines | [no description available] | medium | 4 | 0 | | |
niacinamide | [no description available] | medium | 6 | 0 | pyridine alkaloid; pyridinecarboxamide; vitamin B3 | anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor |
probenecid | [no description available] | medium | 1 | 0 | benzoic acids; sulfonamide | uricosuric drug |
cyanides | [no description available] | medium | 2 | 0 | pseudohalide anion | EC 1.9.3.1 (cytochrome c oxidase) inhibitor |
sodium dodecyl sulfate | [no description available] | medium | 1 | 0 | organic sodium salt | detergent; protein denaturant |
lobeline | [no description available] | medium | 2 | 0 | | |
4-chloromercuribenzenesulfonate | [no description available] | medium | 1 | 0 | arenesulfonic acid; arylmercury compound | |
glycine | [no description available] | medium | 1 | 0 | alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical |
proline | [no description available] | medium | 1 | 0 | amino acid zwitterion; glutamine family amino acid; L-alpha-amino acid; proline; proteinogenic amino acid | algal metabolite; compatible osmolytes; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
asparagine | [no description available] | medium | 1 | 0 | amino acid zwitterion; asparagine; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
glutamine | [no description available] | medium | 1 | 0 | amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
aminooxyacetic acid | [no description available] | medium | 1 | 0 | amino acid; hydroxylamines; monocarboxylic acid | anticonvulsant; EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor; EC 4.2.1.22 (cystathionine beta-synthase) inhibitor; nootropic agent |
apomorphine | [no description available] | medium | 5 | 0 | aporphine alkaloid | alpha-adrenergic drug; antidyskinesia agent; antiparkinson drug; dopamine agonist; emetic; serotonergic drug |
angiotensin ii | [no description available] | medium | 12 | 0 | amino acid zwitterion; angiotensin II | human metabolite |
oxytocin | [no description available] | medium | 9 | 0 | heterodetic cyclic peptide; peptide hormone | oxytocic; vasodilator agent |
desoxycorticosterone | [no description available] | medium | 4 | 0 | 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; mineralocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
cysteine | [no description available] | medium | 1 | 0 | cysteinium | fundamental metabolite |
phosphatidylcholines | [no description available] | medium | 1 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine | |
burimamide | [no description available] | medium | 1 | 0 | imidazoles | |
thiosulfates | [no description available] | medium | 4 | 0 | divalent inorganic anion; sulfur oxide; sulfur oxoanion | human metabolite |
fenclonine | [no description available] | medium | 3 | 0 | phenylalanine derivative | |
cimetidine | [no description available] | medium | 2 | 0 | aliphatic sulfide; guanidines; imidazoles; nitrile | adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
promethazine | [no description available] | medium | 2 | 0 | phenothiazines; tertiary amine | anti-allergic agent; anticoronaviral agent; antiemetic; antipruritic drug; H1-receptor antagonist; local anaesthetic; sedative |
clonidine | [no description available] | medium | 6 | 0 | clonidine; imidazoline | |
ovalbumin | [no description available] | medium | 1 | 0 | | |
bemegride | [no description available] | medium | 2 | 0 | piperidones | |
diazepam | [no description available] | medium | 2 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
cyproheptadine | [no description available] | medium | 9 | 0 | piperidines; tertiary amine | anti-allergic agent; antipruritic drug; gastrointestinal drug; H1-receptor antagonist; serotonergic antagonist |
pimozide | [no description available] | medium | 3 | 0 | benzimidazoles; heteroarylpiperidine; organofluorine compound | antidyskinesia agent; dopaminergic antagonist; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist |
ergonovine | [no description available] | medium | 2 | 0 | ergot alkaloid; monocarboxylic acid amide; organic heterotetracyclic compound; primary alcohol; secondary amino compound; tertiary amino compound | diagnostic agent; fungal metabolite; oxytocic; toxin |
muscarine | [no description available] | medium | 1 | 0 | monosaccharide | |
nifedipine | [no description available] | medium | 1 | 0 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
practolol | [no description available] | medium | 4 | 0 | acetamides; ethanolamines; propanolamine; secondary alcohol; secondary amino compound | anti-arrhythmia drug; beta-adrenergic antagonist |
dihydroergotoxine | [no description available] | medium | 1 | 0 | | |
tetrodotoxin | [no description available] | medium | 7 | 0 | azatetracycloalkane; oxatetracycloalkane; quinazoline alkaloid | animal metabolite; bacterial metabolite; marine metabolite; neurotoxin; voltage-gated sodium channel blocker |
picrotoxin | [no description available] | medium | 8 | 0 | | |
bicuculline | [no description available] | medium | 2 | 0 | benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines | agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin |
strychnine | [no description available] | medium | 8 | 0 | monoterpenoid indole alkaloid; organic heteroheptacyclic compound | avicide; cholinergic antagonist; glycine receptor antagonist; neurotransmitter agent; rodenticide |
moxidectin | [no description available] | medium | 1 | 0 | | |
bunazosin | [no description available] | medium | 1 | 0 | quinazolines | |
quinazolines | [no description available] | medium | 1 | 0 | azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinazolines | |
bethanechol | [no description available] | medium | 1 | 0 | carbamate ester; quaternary ammonium ion | muscarinic agonist |
triiodothyronine | [no description available] | medium | 1 | 0 | 2-halophenol; amino acid zwitterion; iodophenol; iodothyronine | human metabolite; mouse metabolite; thyroid hormone |
pindolol | [no description available] | medium | 1 | 0 | indoles; secondary amine | antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; serotonergic antagonist; vasodilator agent |
desipramine | [no description available] | medium | 5 | 0 | dibenzoazepine; secondary amino compound | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor |
strontium | [no description available] | medium | 2 | 0 | alkaline earth metal atom | |
scopolamine hydrobromide | [no description available] | medium | 5 | 0 | | |
naphazoline | [no description available] | medium | 3 | 0 | naphthalenes | |
proglumide | [no description available] | medium | 1 | 0 | benzamides; dicarboxylic acid monoamide; glutamine derivative; racemate | anti-ulcer drug; cholecystokinin antagonist; cholinergic antagonist; delta-opioid receptor agonist; drug metabolite; gastrointestinal drug; opioid analgesic; xenobiotic metabolite |
cholecystokinin | [no description available] | medium | 2 | 0 | | |
quipazine | [no description available] | medium | 1 | 0 | piperazines; pyridines | |
guanosine triphosphate | [no description available] | medium | 1 | 0 | guanosine 5'-phosphate; purine ribonucleoside 5'-triphosphate | Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor |
8-hydroxy-2-(di-n-propylamino)tetralin | [no description available] | medium | 1 | 0 | phenols; tertiary amino compound; tetralins | serotonergic antagonist |
n,n-dimethyltryptamine | [no description available] | medium | 1 | 0 | tryptamine alkaloid; tryptamines | |
5-methoxytryptamine | [no description available] | medium | 1 | 0 | aromatic ether; primary amino compound; tryptamines | 5-hydroxytryptamine 2A receptor agonist; 5-hydroxytryptamine 2B receptor agonist; 5-hydroxytryptamine 2C receptor agonist; antioxidant; cardioprotective agent; human metabolite; mouse metabolite; neuroprotective agent; radiation protective agent; serotonergic agonist |
tryptamine | [no description available] | medium | 1 | 0 | aminoalkylindole; aralkylamino compound; indole alkaloid; tryptamines | human metabolite; mouse metabolite; plant metabolite |
bufotenin | [no description available] | medium | 1 | 0 | tertiary amine; tryptamine alkaloid | coral metabolite; hallucinogen |
n-methyltryptamine | [no description available] | medium | 1 | 0 | tryptamine alkaloid; tryptamines | metabolite |
1-(3-trifluoromethylphenyl)piperazine | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; N-arylpiperazine | environmental contaminant; psychotropic drug; serotonergic agonist; xenobiotic |
5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1h indole | [no description available] | medium | 1 | 0 | indoles | |
talipexole | [no description available] | medium | 1 | 0 | azepine | |
metaraminol | [no description available] | medium | 4 | 0 | phenylethanolamines | alpha-adrenergic agonist; sympathomimetic agent; vasoconstrictor agent |
propylbenzilylcholine mustard | [no description available] | medium | 1 | 0 | | |
cosyntropin | [no description available] | medium | 1 | 0 | | |
physostigmine salicylate | [no description available] | medium | 1 | 0 | azaheterocycle salicylate salt; salicylates | |
gamma-aminobutyric acid | [no description available] | medium | 1 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid | human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule |
hexylresorcinol | [no description available] | medium | 1 | 0 | resorcinols | |
pyrantel tartrate | [no description available] | medium | 1 | 0 | | |
piperazine | [no description available] | medium | 1 | 0 | azacycloalkane; piperazines; saturated organic heteromonocyclic parent | anthelminthic drug |
dimethylphenylpiperazinium iodide | [no description available] | medium | 1 | 0 | N-arylpiperazine; organic iodide salt; piperazinium salt; quaternary ammonium salt | nicotinic acetylcholine receptor agonist |
diethylcarbamazine | [no description available] | medium | 1 | 0 | N-carbamoylpiperazine; N-methylpiperazine | |
beta-carboline-3-carboxylic acid ethyl ester | [no description available] | medium | 1 | 0 | beta-carbolines | |
beta-carboline-3-carboxylic acid methyl ester | [no description available] | medium | 1 | 0 | beta-carbolines | |
isocarboxazid | [no description available] | medium | 3 | 0 | benzenes | |
dihydroxyphenylalanine | [no description available] | medium | 8 | 0 | hydroxyphenylalanine; non-proteinogenic alpha-amino acid; tyrosine derivative | human metabolite |
quinidine | [no description available] | medium | 4 | 0 | cinchona alkaloid | alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker |
potassium chloride | [no description available] | medium | 3 | 0 | inorganic chloride; inorganic potassium salt; potassium salt | fertilizer |
tetracaine | [no description available] | medium | 2 | 0 | benzoate ester; tertiary amino compound | local anaesthetic |
lidocaine | [no description available] | medium | 3 | 0 | benzenes; monocarboxylic acid amide; tertiary amino compound | anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic |
hydroxyindoleacetic acid | [no description available] | medium | 1 | 0 | indole-3-acetic acids | drug metabolite; human metabolite; mouse metabolite |
5-hydroxytryptophan | [no description available] | medium | 4 | 0 | hydroxytryptophan | human metabolite; neurotransmitter |
chlorpheniramine | [no description available] | medium | 5 | 0 | monochlorobenzenes; pyridines; tertiary amino compound | anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor |
adenine | [no description available] | medium | 1 | 0 | 6-aminopurines; purine nucleobase | Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
phosphorus radioisotopes | [no description available] | medium | 1 | 0 | | |
1-propanol | [no description available] | medium | 3 | 0 | propan-1-ols; short-chain primary fatty alcohol | metabolite; protic solvent |
methamphetamine | [no description available] | medium | 2 | 0 | amphetamines; secondary amine | central nervous system stimulant; environmental contaminant; neurotoxin; psychotropic drug; xenobiotic |
isoniazid | [no description available] | medium | 1 | 0 | carbohydrazide | antitubercular agent; drug allergen |
caffeine | [no description available] | medium | 5 | 0 | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic |
caseins | [no description available] | medium | 1 | 0 | | |
albuterol | [no description available] | medium | 1 | 0 | phenols; phenylethanolamines; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic |
terbutaline | [no description available] | medium | 1 | 0 | phenylethanolamines; resorcinols | anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; hypoglycemic agent; sympathomimetic agent; tocolytic agent |
alpha-chymotrypsin | [no description available] | medium | 2 | 0 | | |
moxisylyte | [no description available] | medium | 1 | 0 | monoterpenoid | |
carbon tetrachloride | [no description available] | medium | 3 | 0 | chlorocarbon; chloromethanes | hepatotoxic agent; refrigerant |
corticosterone | [no description available] | medium | 3 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
croton oil | [no description available] | medium | 1 | 0 | N-acyl-hexosamine | |
thymidine | [no description available] | medium | 1 | 0 | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite |
oxazoles | [no description available] | medium | 1 | 0 | 1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
nialamide | [no description available] | medium | 4 | 0 | organonitrogen compound; organooxygen compound | |
benactyzine | [no description available] | medium | 3 | 0 | diarylmethane | |
imipramine | [no description available] | medium | 6 | 0 | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
phenyl acetate | [no description available] | medium | 1 | 0 | benzenes; phenyl acetates | |
isosorbide dinitrate | [no description available] | medium | 1 | 0 | glucitol derivative; nitrate ester | nitric oxide donor; vasodilator agent |
normetanephrine | [no description available] | medium | 2 | 0 | catecholamine | |
phosphocreatine | [no description available] | medium | 3 | 0 | phosphagen; phosphoamino acid | human metabolite; mouse metabolite |
p-methoxy-n-methylphenethylamine | [no description available] | medium | 1 | 0 | aromatic ether; secondary amino compound | metabolite |
scandium | [no description available] | medium | 1 | 0 | d-block element atom; rare earth metal atom; scandium group element atom | |
lead | [no description available] | medium | 1 | 0 | carbon group element atom; elemental lead; metal atom | neurotoxin |
formaldehyde | [no description available] | medium | 1 | 0 | aldehyde; one-carbon compound | allergen; carcinogenic agent; disinfectant; EC 3.5.1.4 (amidase) inhibitor; environmental contaminant; Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
thromboplastin | [no description available] | medium | 1 | 0 | | |
ethacrynic acid | [no description available] | medium | 1 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic |
oligomycins | [no description available] | medium | 1 | 0 | | |
sotalol | [no description available] | medium | 2 | 0 | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic |
glycogen | [no description available] | medium | 1 | 0 | | |
dextroamphetamine | [no description available] | medium | 5 | 0 | 1-phenylpropan-2-amine | adrenergic agent; adrenergic uptake inhibitor; dopamine uptake inhibitor; dopaminergic agent; neurotoxin; sympathomimetic agent |
mecamylamine | [no description available] | medium | 6 | 0 | primary aliphatic amine | |
nortriptyline | [no description available] | medium | 1 | 0 | organic tricyclic compound; secondary amine | adrenergic uptake inhibitor; analgesic; antidepressant; antineoplastic agent; apoptosis inducer; drug metabolite |
morphine | [no description available] | medium | 12 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound | anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic |
pyrogallol | [no description available] | medium | 8 | 0 | benzenetriol; phenolic donor | plant metabolite |
succinylcholine | [no description available] | medium | 1 | 0 | quaternary ammonium ion; succinate ester | drug allergen; muscle relaxant; neuromuscular agent |
bromine | [no description available] | medium | 2 | 0 | diatomic bromine | |
bradykinin | [no description available] | medium | 3 | 0 | oligopeptide | human blood serum metabolite; vasodilator agent |
arginine | [no description available] | medium | 1 | 0 | arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical |
amantadine | [no description available] | medium | 1 | 0 | adamantanes; primary aliphatic amine | analgesic; antiparkinson drug; antiviral drug; dopaminergic agent; NMDA receptor antagonist; non-narcotic analgesic |
disulfiram | [no description available] | medium | 2 | 0 | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor |
phenylalanine | [no description available] | medium | 1 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
perphenazine | [no description available] | medium | 1 | 0 | N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; organochlorine compound; phenothiazines | antiemetic; dopaminergic antagonist; phenothiazine antipsychotic drug |
pargyline | [no description available] | medium | 2 | 0 | aromatic amine | |
chloroform | [no description available] | medium | 5 | 0 | chloromethanes; one-carbon compound | carcinogenic agent; central nervous system drug; inhalation anaesthetic; non-polar solvent; refrigerant |
procainamide | [no description available] | medium | 1 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
aminopyrine | [no description available] | medium | 1 | 0 | pyrazolone; tertiary amino compound | antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
mefenamic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; secondary amino compound | analgesic; antipyretic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic |
phenelzine | [no description available] | medium | 2 | 0 | primary amine | |
puromycin | [no description available] | medium | 1 | 0 | puromycins | antiinfective agent; antimicrobial agent; antineoplastic agent; EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor; EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor; nucleoside antibiotic; protein synthesis inhibitor |
ampicillin | [no description available] | medium | 1 | 0 | beta-lactam antibiotic; penicillin allergen; penicillin | antibacterial drug |
toluene | [no description available] | medium | 1 | 0 | methylbenzene; toluenes; volatile organic compound | cholinergic antagonist; fuel additive; neurotoxin; non-polar solvent |
diazoxide | [no description available] | medium | 1 | 0 | benzothiadiazine; organochlorine compound; sulfone | antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent |
dibucaine | [no description available] | medium | 1 | 0 | aromatic ether; monocarboxylic acid amide; tertiary amino compound | topical anaesthetic |
indomethacin | [no description available] | medium | 1 | 0 | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic |
pempidine | [no description available] | medium | 3 | 0 | piperidines | |
ascorbic acid | [no description available] | medium | 3 | 0 | ascorbic acid; vitamin C | coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent |
sucrose | [no description available] | medium | 1 | 0 | glycosyl glycoside | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent |
mercury | [no description available] | medium | 1 | 0 | elemental mercury; zinc group element atom | neurotoxin |
ethylmaleimide | [no description available] | medium | 1 | 0 | maleimides | anticoronaviral agent; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.1.1 (hexokinase) inhibitor |
dimethylformamide | [no description available] | medium | 1 | 0 | formamides; volatile organic compound | geroprotector; hepatotoxic agent; polar aprotic solvent |
chlorine | [no description available] | medium | 3 | 0 | diatomic chlorine; gas molecular entity | bleaching agent |
urea | [no description available] | medium | 1 | 0 | isourea; monocarboxylic acid amide; one-carbon compound | Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
trimethadione | [no description available] | medium | 1 | 0 | oxazolidinone | anticonvulsant; geroprotector |
amobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
arecoline | [no description available] | medium | 1 | 0 | enoate ester; methyl ester; pyridine alkaloid; tetrahydropyridine | metabolite; muscarinic agonist |
obidoxime chloride | [no description available] | medium | 1 | 0 | | |
furaldehyde | [no description available] | medium | 1 | 0 | aldehyde; furans | Maillard reaction product; metabolite |
bromide | [no description available] | medium | 1 | 0 | halide anion; monoatomic bromine | |
hemicholinium 3 | [no description available] | medium | 1 | 0 | | |
beta-aminoethyl isothiourea | [no description available] | medium | 1 | 0 | | |
thioacetamide | [no description available] | medium | 1 | 0 | thiocarboxamide | hepatotoxic agent |
galactose | [no description available] | medium | 1 | 0 | | |
cysteamine | [no description available] | medium | 1 | 0 | amine; thiol | geroprotector; human metabolite; mouse metabolite; radiation protective agent |
methanol | [no description available] | medium | 2 | 0 | alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound | amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite |
thiopental | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant; drug allergen; environmental contaminant; intravenous anaesthetic; sedative; xenobiotic |
tranylcypromine | [no description available] | medium | 1 | 0 | 2-phenylcyclopropan-1-amine | |
pentazocine | [no description available] | medium | 1 | 0 | benzazocine | |
eledoisin | [no description available] | medium | 2 | 0 | peptide | |
tetrabenazine | [no description available] | medium | 2 | 0 | benzoquinolizine; cyclic ketone; tertiary amino compound | |
chondroitin | [no description available] | medium | 1 | 0 | | |
limestone | [no description available] | medium | 1 | 0 | calcium salt; carbonate salt; inorganic calcium salt; one-carbon compound | antacid; fertilizer; food colouring; food firming agent |
trichloroacetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid; organochlorine compound | carcinogenic agent; metabolite; mouse metabolite |
tromethamine | [no description available] | medium | 1 | 0 | primary amino compound; triol | buffer |
metyrapone | [no description available] | medium | 1 | 0 | aromatic ketone | antimetabolite; diagnostic agent; EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor |
chlordiazepoxide | [no description available] | medium | 1 | 0 | benzodiazepine | |
tyrosine | [no description available] | medium | 1 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical |
tremorine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine | |
carbon monoxide | [no description available] | medium | 1 | 0 | carbon oxide; gas molecular entity; one-carbon compound | biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent |
azides | [no description available] | medium | 1 | 0 | pseudohalide anion | mitochondrial respiratory-chain inhibitor |
aspirin | [no description available] | medium | 1 | 0 | benzoic acids; phenyl acetates; salicylates | anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent |
stilbenes | [no description available] | medium | 1 | 0 | stilbene | |
trolamine salicylate | [no description available] | medium | 1 | 0 | | |
digitoxin | [no description available] | medium | 1 | 0 | cardenolide glycoside | EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor |
fomesafen | [no description available] | medium | 5 | 0 | aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
eye | [no description available] | medium | 2 | 0 | | |
egg white | [no description available] | medium | 1 | 0 | | |
humulene | [no description available] | medium | 1 | 0 | alpha-humulene | |
2-propanol | [no description available] | medium | 2 | 0 | secondary alcohol; secondary fatty alcohol | protic solvent |
apnea | [no description available] | medium | 1 | 0 | purine nucleoside | |